Abstract Objective To explore the advantages of urinary matrix metalloproteinase-7 (MMP-7) in evaluating renal tubular injury minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) patients compared with cystatin C (CysC) retinol binding protein (RBP). Methods Serum urine samples were collected from 20 healthy volunteers, 40 MCD FSGS patients. MMP-7 levels measured by enzyme...